BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
10.20
+0.21 (2.10%)
Aug 15, 2025, 12:29 PM - Market open
Company Description
BridgeBio Oncology Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing a pipeline of novel small molecule therapeutics targeting RAS and PI3Kα malignancies.
The company is based in South San Francisco, California. BridgeBio Oncology Therapeutics, Inc. operates as a subsidiary of BridgeBio Pharma, Inc.
BridgeBio Oncology Therapeutics, Inc.
| Country | United States |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Eli Wallace |
Contact Details
Address: 256 E. Grand Avenue, Suite 104 South San Francisco, California 94080 United States | |
| Phone | 650 405 4770 |
| Website | bbotx.com |
Stock Details
| Ticker Symbol | BBOT |
| Exchange | NASDAQ |
| Reporting Currency | USD |
Key Executives
| Name | Position |
|---|---|
| Eli Wallace | Chief Executive Officer |
| Uneek Mehra | Chief Financial Officer |
| Howard Chang | Chief Operating Officer |